No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ASRT Assertio
- 0.886
- +0.043+5.09%
Close Dec 20 16:00 ET
- 0.908
- +0.023+2.54%
Post 20:01 ET
84.58MMarket Cap-2.01P/E (TTM)
0.909High0.810Low755.53KVolume0.823Open0.843Pre Close667.35KTurnover0.89%Turnover RatioLossP/E (Static)95.48MShares1.79852wk High0.65P/B75.00MFloat Cap0.73252wk Low--Dividend TTM84.65MShs Float134.960Historical High--Div YieldTTM11.76%Amplitude0.732Historical Low0.883Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Assertio Therapeutics Announces Leadership Changes and Board Addition
Express News | Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
Press Release: Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
H.C. Wainwright Maintains Assertio(ASRT.US) With Buy Rating, Maintains Target Price $4
HC Wainwright & Co. Reiterates Buy on Assertio Holdings, Maintains $4 Price Target
Promising Buy Rating for Assertio Therapeutics Backed by Positive ROLVEDON Trial Results and Market Potential
Heat List
US
Overall
Symbol
Price
% Chg
No Data